Department of Chemistry, University of Minnesota, 207 Pleasant St. SE, Minneapolis, Minnesota 55455, United States.
Institute for Therapeutics Discovery and Development, Department of Medicinal Chemistry, University of Minnesota, 717 Delaware Street SE, Minneapolis, Minnesota 55414, United States.
ACS Chem Biol. 2020 Nov 20;15(11):3038-3049. doi: 10.1021/acschembio.0c00720. Epub 2020 Nov 3.
Multidomain bromodomain-containing proteins regulate gene expression via chromatin binding, interactions with the transcriptional machinery, and by recruiting enzymatic activity. Selective inhibition of members of the bromodomain and extra-terminal (BET) family is important to understand their role in disease and gene regulation, although due to the similar binding sites of BET bromodomains, selective inhibitor discovery has been challenging. To support the bromodomain inhibitor discovery process, here we report the first application of protein-observed fluorine (PrOF) NMR to the tandem bromodomains of BRD4 and BRDT to quantify the selectivity of their interactions with acetylated histones as well as small molecules. We further determine the selectivity profile of a new class of ligands, 1,4-acylthiazepanes, and find them to have ≥3-10-fold selectivity for the C-terminal bromodomain of both BRD4 and BRDT. Given the speed and lower protein concentration required over traditional protein-observed NMR methods, we envision that these fluorinated tandem proteins may find use in fragment screening and evaluating nucleosome and transcription factor interactions.
多结构域溴结构域蛋白通过与染色质结合、与转录机制相互作用以及招募酶活性来调节基因表达。选择性抑制溴结构域和末端(BET)家族的成员对于了解它们在疾病和基因调控中的作用非常重要,尽管由于 BET 溴结构域具有相似的结合位点,因此选择性抑制剂的发现具有挑战性。为了支持溴结构域抑制剂的发现过程,在这里,我们首次将蛋白质观察氟(PrOF)NMR 应用于 BRD4 和 BRDT 的串联溴结构域,以定量评估它们与乙酰化组蛋白以及小分子相互作用的选择性。我们进一步确定了一类新配体 1,4-酰基噻唑烷的选择性特征,发现它们对 BRD4 和 BRDT 的 C 端溴结构域具有≥3-10 倍的选择性。鉴于传统的蛋白质观察 NMR 方法所需的速度和较低的蛋白质浓度,我们设想这些氟化串联蛋白可能会在片段筛选和评估核小体和转录因子相互作用中找到用途。